Abstracts

Geier 2015 – Thimerosal exposure and increased risk for diagnosed tic disorder in the United States: a case-control study

Geier 2010 – The Biological Basis of Autism Spectrum Disorders: Understanding Causation and Treatment by Clinical Geneticists

Jeong 2017 – High Mernal Blood Mercury Level is Associated with Low Verbal IQ in Children

Jin 2004-Thimerosal decreases TRPV1 activity by oxidation of extracellular sulfhydryl residues

Kaplin 1994 – Purified Reconstituted Inositol 1,4,5-Triphosphate Receptors

Karsen 2007 – Apparent vaccine-thimerosal induced hypersensitivity myelodysplastic syndrome and pancytopenia

Geier 2009 – A Prospective Study of Prenatal Mercury Exposure From Maternal Dental Amalgams and Autism Severity

Kempuraj 2010 – Mercury induces inflammatory mediator release from human mast cells

Kern 2010 – A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder

Geier 2009 – A Prospective Blinded Evaluation or Urinary Porphyrins Verses the Clinical Severity of Autism Spectrum Disorders

Kern 2010 – Toxicity biomarkers in autism spectrum disorder: A blinded study of urinary porphyrins

Geier 2008 – Neurodevelopment Disorders, Maternal Rh-Negativity, and Rho(D) Immune Globulins: A Multi-Center Assessment

Kern 2016 – The relationship between mercury and autism: A comprehensive review and discussion

Khan 2012 – Sex-dependent Changes in Cerebellar Thyroid Hormone-dependent Gene Expression Following Perinatal Exposure to Thimerosal in Rats

Kim 2002 – Thimerosal stimulates focal adhesion kinase and cytoskeletal changes by redox modulation

Geier 2006 – An Assessment of Downward Trends in Neurodevelopment Disorders in the United States Folloing Removal of Thimerosal from Childhood Vaccines

Kramer 2004 – Mercury exposure in protein A immunoadsorption

Lawton 2007 -Reduced tubulin tyrosination as an early marker of mercury toxicity in differentiating N2a cells

Geier 2006 – A Prospective Study of Thimerosal-containing Rho(D)-immune globulin Administration as a Risk Factor for Autistic Disorders

Lee 2006 – Thimerosal induces oxidative stress in HeLa S epithelial cells

Leventhal 2012 – Hypersensitivity Reactions to Vaccine Constituents: A Case Series and Review of the Literature

Li 2000 – Mercury intoxication presenting with tics

Geier 2006 – A Prospective Assessment of Porphyrins in Autistic Disorders: A Potential Marker for Heavy Metal Exposure

Li 2012 – Thimerosal-Induced Apoptosis in Mouse C2C12 Myoblast Cells Occurs through Suppression of the P13K/Akt/ Surviving Pathway

Madi 2004 – Being on the Track of Thimerosal

Geier 2005 – The Potential importance of Steroids in the Treatment of Autistic Spectrum Disorders and Other Disorders Involving Mercury Toxicity

Magos 2001 – Review on the Toxicity of Ethylmercury, Including its Presence as a Preservative in Biological and Pharmaceutical Products

Marques 2008 – Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury

Marques 2009 – Prenatal and Postnatal Mercury Exposure, Breastfeeding and Neurodevelopment During the First 5 Years

Marques 2010 – Thimerosal exposure (from tetanus-diphtheria) during pregnancy and neurodevelopment of breastfed infants at 6 months